PharVision Advisers’s Opendoor OPEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.3K Buy
16,091
+1,236
+8% +$5.92K 1.4% 38
2026
Q1
$69.5K Buy
+14,855
New +$80K 0.71% 74

Other funds holding OPEN

PharVision Advisers's OPEN Position: Q2 2026 in Review

PharVision Advisers increased its Opendoor (OPEN) stake by 8.3% in Q2 2026, buying an estimated $5.92K and bringing the position to 16,091 shares worth $74.3K. The position accounts for 1.4% of the portfolio, ranked #38.

PharVision Advisers first reported a position in OPEN in Q1 2026 and has held it in 2 quarters since. 391 funds tracked by Wall St. Rank hold OPEN as of Q2 2026.

  • PharVision Advisers held 16,091 shares of Opendoor worth $74.3K as of Q2 2026.
  • PharVision Advisers bought 1,236 Opendoor shares in Q2 2026, an estimated $5.92K.
  • Opendoor made up 1.4% of PharVision Advisers's portfolio in Q2 2026, its #38 holding.
  • PharVision Advisers first reported a position in Opendoor in Q1 2026 and has held it in 2 quarters since.
  • 391 funds tracked by Wall St. Rank held Opendoor as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.